Advanced Flower Capital (AFCG) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
13 Aug, 2026Executive summary
Completed conversion from a REIT to a BDC on January 1, 2026, expanding lending flexibility and industry reach beyond cannabis.
Net investment income for Q2 2026 was $0.15 per share, with a $0.05 per share distribution paid on July 15, 2026.
Share repurchases totaled $2.8 million, accretive by $0.17 to NAV; 839,406 shares repurchased at $3.29 average price.
Senior leadership has structured over $10 billion in loans and taken five companies public.
Lending focus remains on lower middle market U.S. companies with $5–$50 million EBITDA, emphasizing sponsor relationships and strong covenant packages.
Financial highlights
Net asset value per share increased to $8.25 at June 30, 2026, up from $7.90 at March 31, 2026.
Total investment income for Q2 2026 was $8.7 million; net investment income was $3.5 million.
Portfolio fair value reached $289.8 million across 17 companies as of June 30, 2026.
Net increase in net assets from operations was $5.4 million for Q2 2026.
Portfolio commitments increased to $385.7 million as of August 3, 2026.
Outlook and guidance
Pipeline remains active at $1.3 billion, with focus on cash-flowing borrowers in the $5–15 million EBITDA range.
Management expects continued portfolio growth and diversification, prioritizing credit quality and risk-adjusted returns.
Sufficient liquidity and capital resources projected to meet operating and investment needs for at least the next twelve months.
Originations expected to be lumpy and episodic, but quality and pricing of opportunities remain strong.
Total available liquidity exceeded $70 million.
Latest events from Advanced Flower Capital
- All proposals passed, including director reelections and auditor ratification.AFCG
AGM 2026 - Q1 2026 net investment income was $4.8M, NAV per share rose to $7.90, and a $5M buyback was authorized.AFCG
Q1 2026 - Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCG
Investor presentation - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing - Vote on director elections and auditor ratification at the May 2026 annual meeting.AFCG
Proxy filing - BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCG
Q4 2025 - Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 2025 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 2024 - Q1 2025 net income $4.1M, $0.21/share Distributable Earnings, $0.23 dividend, 18% yield.AFCG
Q1 2025